期刊文献+

过表达整合素连接激酶可改善慢性心力衰竭大鼠心功能 被引量:15

Overexpression of integrin-linked kinase improves cardiac function in a rat model of doxorubicin induced chronic heart failure
原文传递
导出
摘要 目的 观察心脏转染整合素连接激酶(ILK)对心力衰竭大鼠心功能的影响,并初步探讨其机制.方法 腹腔注射阿霉素(总剂量15 mg/kg,2周内分6次注射)建立大鼠心力衰竭模型.5周后通过心脏超声筛查,将成功建模的大鼠按照随机数字表法随机分为转染Ad-ILK组(Ad-ILK组)和转染Ad-null组(对照组),每组20只.通过开胸左心室多点注射Ad-ILK或Ad-null,4周后采用蛋白质免疫印迹法检测ILK蛋白表达水平及其活性,超声心动图、心导管法检测大鼠心功能,ELISA法检测大鼠血清B型利钠肽(BNP)表达水平,并采用TUNEL法检测心肌细胞凋亡率,磷酸化组蛋白H3免疫荧光染色检测心肌细胞增殖率.结果 转染4周后,Ad-ILK组大鼠心脏组织中ILK蛋白表达水平明显高于对照组(P<0.05),其下游蛋白激酶B(Akt)磷酸化水平也明显高于对照组(P<0.05).转染4周后,Ad-ILK组大鼠左心室射血分数和短轴缩短率均明显高于对照组[(60.56±2.61)%比(51.94±2.28)%和(28.10±1.83)%比(22.82±1.68)%,P均<0.05],左心室舒张末期内径和收缩末期内径均明显小于对照组[(6.22±0.24) mm比(7.15±0.21) mm和(4.42±0.23) mm比(5.65±0.25) mm,P均<0.05],左心室舒张末压明显低于对照组[(12.96±2.10) mmHg比(21.45±2.48) mmHg(1 mmHg =0.133 kPa),P<0.05].Ad-ILK组大鼠血清B型利钠肽水平亦明显低于对照组(P<0.05).Ad-ILK组心肌细胞凋亡率明显低于对照组[(0.23±0.02)%比(0.45±0.04)%,P<0.05],而心肌细胞增殖率则显著高于对照组[(0.60±0.07)%比(0.24±0.03)%,P<0.01].结论 心肌注射转染Ad-ILK能够明显改善心力衰竭大鼠心功能,这一作用可能与过表达ILK能够抑制心肌细胞凋亡、促进心肌细胞增殖有关. Objective The aim of this study is to investigate the effects of cardiac integrin-linked kinase (ILK) overexpression in a rat model of doxorubicin-indueed heart failure and the underlying mechanisms. Methods Rat heart failure model was induced by intraperitoneal administration of doxorubicin (6 injections within 2 weeks: total dose = 15 mg/kg). Five weeks after the first injection, rats with heart failure were confirmed by echocardiography and then randomly divided into Ad-ILK group (intramyocardially injected with adenoviral vector expressing ILK) and Ad-null group (intramyoeardially injected with empty ad-null, n =20 each). After 4 weeks, ILK expression and activity were detected by Western blot, cardiac function was determined by echocardiographie and hemodynamic examinations. Apoptosis was measured by TUNEL analysis and cardiomyocyte proliferation was estimated by phosphohistone-H3 staining. Results Western blot analysis revealed higher expression of ILK as well as the phospholylation levels of Akt in Ad- ILK hearts as compared with ad-null controls. Four weeks after transfection, LVEF and LVFS were significantly higher in Ad-ILK group as compared with control grotlp LVEF: (60. 56 ±2.61 )% vs. (51.94±2.28)%, P〈0.05; LVFS: (28. 10± 1.83)% vs. (22.82 ± 1.68)%, P 〈0.05]. The LVEDD and LVESD, as well as LVEDP were significantly lower in Ad-ILK group compared with control group [LVEDD: (6.22±0.24) mmvs. (7.15±0.21) ram, P〈0.05; LVESD: (4.42±0.23) mmvs. (5.65 ±0.25) ram, P〈0.05; LVEDP: (12.96±2.10) mmHgvs. (21.45±2.48) mmHg(1 mmHg=0. 133 kPa) , P 〈0. 05]. Reduced levels of serum BNP was also seen in the Ad-ILK group. TUNEL analysis showed that ILK treatment significantly inhibited the apoptosis of cardioInyoeytes [ ( 0. 23 ± 0. 02 ) % vs. (0. 45 ± 0.04)% , P 〈 0. 05 ]. Moreover, increased cardiomyocyte proliferation was found in Ad-ILK group through the phospho-histone H3 staining [ (0. 60 ± 0.07 ) % vs. �
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2014年第3期225-229,共5页 Chinese Journal of Cardiology
基金 国家自然科学基金(81000055,81070195)
关键词 心力衰竭 充血性 细胞增殖 细胞凋亡 整合素连接激酶 Heart failure, congestive Cell proliferation Apoptosis Integrin-linked kinase
  • 相关文献

参考文献17

  • 1Zittermann A, Schleithoff SS, Getting C,et al. Poor outcome inend-stage heart failure patients with low circulating calcitriol levels[J]. Eur J Heart Fail, 2008, 10: 321-327. 被引量:1
  • 2Hannigan G,Troussard AA,Dedhar S. Integrin-linked kinase: acancer therapeutic target unique among its ILK [J]. Nat RevCancer,2005 , 5 ; 51 -63. 被引量:1
  • 3White DE, Coutu P, Shi YF, et al. Targeted ablation of ILK fromthe murine heart results in dilated cardiomyopathy and spontaneousheart failure[J]. Genes Dev, 2006, 20: 2355-2360. 被引量:1
  • 4Suzuki K, Murtuza B, Suzuki N, et al. Intracoronary infusion ofskeletal myoblasts improves cardiac function in doxorubicin-induced heart failure [J]. Circulation, 2001, 104 ( 12Suppl 1):1213-1217. 被引量:1
  • 5Engel FB, Schebesta M,Duong MT, et al. p38 MAP kinaseinhibition enables proliferation of adult mammaliancardiorayocytes. Genes Dev, 2005 , 19: 1175-1187. 被引量:1
  • 6Hannigan GE, Coles JG,Dedhar S, Integrin-linked kinase at theheart of cardiac contractility,repair,and disease [J] . Circ Res,2007, 100: 1408-1414. 被引量:1
  • 7Bock-Marquette I,Saxena A, White MD, et al. Thymosin beta4activates integrin-linked kinase and promotes cardiac cellmigration,survival and cardiac repair [J]. Nature, 2004,432 :466472. 被引量:1
  • 8Bendig G,Grimraler M,Huttner IG, et al. Integrin-linkedkinase,a novel component of the cardiac mechanical stretchsensor,controls contractility in the zebrafish heart [J]. GenesDev, 2006, 20: 2361-2372. 被引量:1
  • 9Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes inend-stage heart failure [J]. N Engl J Med, 1996,335 : 1182-1189. 被引量:1
  • 10Wencker D, Chandra M, Nguyen K, et al. A mechanistic role forcardiac myocyte apoptosis in heart failure [J]. J Clin Invest,2003, 111: 1497-1504. 被引量:1

同被引文献55

  • 1李小鹰.肌浆网钙ATP酶2a基因转导治疗心力衰竭的研究[J].中华心血管病杂志,2005,33(6):576-578. 被引量:12
  • 2陈可远.充血性心力衰竭从肺论治[J].北京中医药大学学报(中医临床版),2006,13(1):27-28. 被引量:5
  • 3Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: mechanisms: part 1 of 2 [J]. Circulation, 2013, 128(4): 388-400. 被引量:1
  • 4Braunwald E. The war against heart failure: the Lancet lecture[J]. Lancet, 2015, 385 (9970): 812-824. 被引量:1
  • 5Konstam MA, Kramer DG, Patel AR, et al. Left ven- tricular remodeling in heart failure: current concepts in clinical significance and assessment [J]. JACC Cardio- vasclmaging, 2011, 4(1): 98-108. 被引量:1
  • 6McMurray JJ. Clinical practice. Systolic heart failure[J]. N EnglJ Med, 2010, 362(3): 228-238. 被引量:1
  • 7Shah AM, Mann DL. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science[J]. Lancet, 2011, 378(9792): 704- 712. 被引量:1
  • 8Suzuki K, Murtuza B, Suzuki N, et al. Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin induced heart failure [J]. Circulation, 2001, 104(12Supp11): 1213-1217. 被引量:1
  • 9Kurdi M, Booz GW. New Take on the Role of An- giotensin Ⅱ in cardiac hypertrophy and fibrosis[J]. Hy- pertension, 2011, 57(6): 1034-1038. 被引量:1
  • 10Hughes SE. The pathology of hypertrophic cardiomy- opathy[J]. Histopathology, 2004, 44(5}: 412-427. 被引量:1

引证文献15

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部